Found 11 matching trials
Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI
PHASE2This study was designed to evaluate the efficacy and safety of cadonilimab ...
Location
Guangdong Provincial Hospital of Traditional Chinese Medicine
Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer
PHASE2This study aims to evaluate the safety and preliminary efficacy of anlotini...
Status
Active Not Recruiting
Location
West China Hospital, Sichuan University
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
PHASE2Objective to evaluate the efficacy and safety of candonilimab combined with...
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)
PHASE2GLOBOCAN 2020 reported that the global incidence of esophageal cancer climb...
Location
Fourth Hospital of Hebei Medical University
Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
PHASE2The goal of this clinical trial is to learn if cadonilimab combined with an...
Location
Multiple Locations
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
PHASE2This study is an open-label, multicenter, single-arm Phase II clinical stud...
Location
Multiple Locations
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
PHASE2Patients with salivary gland carcinoma were divided into groups according t...
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
PHASE2The goal of this clinical trial is to test a new treatment combination incl...
Location
Zhongnan Hospital of Wuhan University
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1This phase Ib/II trial studies how well cadonilimab combined with anlotinib...
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC
NA* 1\. Main objective: to evaluate the pathological complete response (pCR) ...
Location
The First Affiliated Hospital of Air Force Military Medical University